Press release
Medicated Shampoo Market Study Highlights How Industry Demand Is Evolving
The medicated shampoo market is on track for significant expansion over the coming years, driven by various health trends and consumer preferences. This sector is evolving rapidly as more individuals seek effective scalp care solutions that cater to specific dermatological conditions. Let's explore the anticipated market size, key players, emerging trends, and segmentation details shaping the future of medicated shampoos worldwide.Projected Market Size and Growth of the Medicated Shampoo Market
The global medicated shampoo market is forecasted to grow steadily, reaching a valuation of $17.86 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 5.2% throughout the forecast period. Several factors contribute to this upward trajectory, including the rising incidence of psoriasis and fungal infections, an increasing desire for personalized scalp care products, the rapid expansion of online sales platforms, and a stronger focus on preventive treatments for hair loss. Additionally, innovation in active ingredient formulations continues to drive market momentum. Notable trends include the increasing demand for targeted scalp therapies, a preference for dermatologist-recommended shampoos, a surge in the use of herbal and natural medicated products, growth in over-the-counter options, and heightened consumer awareness around maintaining scalp hygiene and health.
The medicated shampoo market size has grown strongly in recent years. It will grow from $13.84 billion in 2025 to $14.59 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increase in dandruff and scalp disorders, rising urban pollution exposure, growth of pharmacy retail chains, higher awareness of hair and scalp hygiene, availability of otc medicated shampoos.
Download a free sample of the medicated shampoo market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24314&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Leading Companies Driving the Medicated Shampoo Industry
The medicated shampoo market is home to several prominent organizations that dominate the competitive landscape. Key players include Johnson & Johnson, The Procter & Gamble Company, Unilever PLC, Kao Corporation, Cipla Limited, The Himalaya Company, Avalon Natural Products Inc., Ederma Pharma India Private Limited, Elegant Cosmed Private Limited, Luxica Pharma Inc., Yaxon Biocare Pvt. Ltd., Art Naturals Inc., Nioxin Research Laboratories Inc., Sulfur 8 Inc., Summer Laboratories Inc., Mars Medisoap Private Limited, Staple Pharmaceuticals Pvt. Ltd., Astonea Labs Limited, ket*opoz Pharmaceuticals Pvt. Ltd., and Maylizz Biotech Private Limited.
Notably, in February 2025, Cosette Pharmaceuticals Inc., a US-based pharmaceutical firm, completed a $430 million acquisition of Mayne Pharma Group Limited. This strategic move aims to bolster Cosette's presence in women's health and dermatology by leveraging Mayne Pharma's established commercial and manufacturing expertise. Mayne Pharma, headquartered in Australia, specializes in producing medicated shampoos, and this acquisition is set to expand global patient access and accelerate innovation in specialty pharmaceuticals.
View the full medicated shampoo market report:
https://www.thebusinessresearchcompany.com/report/medicated-shampoo-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Innovative Trends Shaping the Future of Medicated Shampoos
The industry is witnessing a surge in the development of novel product formulations designed to meet evolving consumer demands. One significant innovation is the introduction of medicated dry shampoos, which offer a convenient, waterless solution for managing scalp conditions. These products combine the oil-absorbing benefits of traditional dry shampoos with therapeutic agents aimed at treating issues such as dandruff, seborrheic dermatitis, and psoriasis.
For instance, in November 2024, Raven Innovations LLC, a US pharmaceutical and personal-care company, launched RestoraScalp, the world's first medicated dry shampoo specifically formulated to address scalp ailments. This product contains 2% salicylic acid as its active ingredient and incorporates a soothing botanical blend featuring chamomile, olive leaf, and green tea extracts. It is vegan, cruelty-free, fragrance-free, and suitable for all skin types, providing an effective treatment option for scalp care on days without washing.
Breakdown of Market Segments in the Medicated Shampoo Industry
The medicated shampoo market is segmented across several dimensions to capture the diversity of products and consumers:
1) By Type:
- Anti-Dandruff
- Antifungal
- Anti-Hair Loss
- Antibacterial or Scalp Treatment
2) By Distribution Channel:
- Pharmacies or Drugstores
- Supermarkets or Hypermarkets
- Online Retail or E-commerce
- Specialty Stores
3) By Application:
- Dandruff
- Seborrheic Dermatitis
- Psoriasis
- Fungal Infections
- Other Applications
4) By End-User:
- Adults
- Children
- Men
- Women
Further subcategories detail specific active ingredients and formulations:
1) Anti-Dandruff shampoos include Zinc Pyrithione, ket*oconazole, Coal-Tar, and Herbal/Natural variants.
2) Antifungal products are divided into ket*oconazole-Based, Selenium Sulfide-Based, and Ciclopirox-Based types.
3) Anti-Hair Loss solutions cover Minoxidil-Based, Biotin or Natural Extracts, and DHT Blockers.
4) Antibacterial or Scalp Treatment shampoos feature ingredients like Salicylic Acid, Climbazole, and Tea Tree Oil.
This thorough segmentation highlights the varied options available to consumers and the innovative approaches companies are taking to meet diverse scalp care needs.
Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Medicated Shampoo Market Study Highlights How Industry Demand Is Evolving here
News-ID: 4609756 • Views: …
More Releases from The Business Research Company
Microbiology And Bacterial Culture Media Market Insights Highlight Segment Expan …
The microbiology and bacterial culture media market is poised for significant expansion as it continues to play a vital role in healthcare, research, and industrial sectors. With evolving technologies and increasing demand for efficient microbial testing, this market is set to witness substantial growth and innovation by 2030.
Projected Growth and Market Size in the Microbiology and Bacterial Culture Media Market
Forecasts indicate that the microbiology and bacterial culture media…
Microbial Identification Market Report Evaluates Growth Drivers, Challenges And …
The microbial identification market is set to experience substantial expansion over the coming years, driven by cutting-edge technological advancements and increasing demand across various industries. With the integration of innovative tools and methodologies, this sector is poised to reach impressive milestones by 2030. Let's explore the market's size, key players, emerging trends, and segmentation to gain a clearer understanding of its future prospects.
Market Size and Growth Expectations in the Microbial…
Micro Computed Tomography Market Report Provides Insights Into Market Evolution …
The micro computed tomography market is on track for substantial expansion in the coming years, driven by technological advancements and a broadening range of applications. As industries and research fields increasingly embrace this imaging technology, the market is poised for significant growth and innovation through 2030.
Expected Market Size and Growth Trajectory of the Micro Computed Tomography Market
The micro computed tomography market is projected to reach a value of…
Methylmalonic Acidemia (MMA) Market Research Explores Growth Within A $13.05 Bil …
The methylmalonic acidemia (MMA) market is poised for substantial growth as advances in treatment and technology continue to evolve. With increasing attention on rare diseases and novel therapeutic approaches, this sector is gaining momentum, offering promising prospects for patients and stakeholders alike. Let's explore the market size, key players, emerging trends, and detailed segmentation shaping the future of MMA treatment.
Projected Expansion of the Methylmalonic Acidemia (MMA) Market by 2030 …
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
